Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PRAsugrel or clopIdogrel in Acute Coronary SyndromE Patients With CYP2C19 Polymorphism (PRAISE-GENE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Dong-A University
Sponsor:
Information provided by (Responsible Party):
Moo Hyun Kim, Dong-A University
ClinicalTrials.gov Identifier:
NCT01641510
First received: July 2, 2012
Last updated: October 25, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2017
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)